Marshall Wace’s Ibere Pharmaceuticals Units IBER.U Stock Holding History
Bought
Maintained
Sold
Other funds holding IBER.U
CCA
Marshall Wace's IBER.U Position: Q2 2021 in Review
Marshall Wace sold out of Ibere Pharmaceuticals Units (IBER.U) in Q2 2021, closing a stake of 450,000 shares — an estimated $4.44M sold.
Marshall Wace first reported a position in IBER.U in Q1 2021 and held it in 1 quarter. The position peaked at $4.44M in Q1 2021. 34 funds tracked by Wall St. Rank hold IBER.U as of Q2 2021.
- Marshall Wace reported no remaining Ibere Pharmaceuticals Units position as of Q2 2021 after selling out during the quarter.
- Marshall Wace sold 450,000 Ibere Pharmaceuticals Units shares in Q2 2021, an estimated $4.44M.
- Marshall Wace first reported a position in Ibere Pharmaceuticals Units in Q1 2021 and held it in 1 quarter.
- Marshall Wace's Ibere Pharmaceuticals Units position peaked at $4.44M in Q1 2021.
- 34 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units as of Q2 2021.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.